340B State Legislation: Illinois

The 340B pricing program enables hospitals in Illinois and across the U.S. to purchase medications at a significant discount and sell them to patients and plan sponsors at the prevailing, if not much higher price. This results in a “buy low, sell high” scheme in which hospital profit significantly at the expense of working families and their employer plan sponsors. Hospitals that participate in the program should pass the 340B savings on to vulnerable patients in local communities, which was the original intent of the 340B program. That is not happening.

Together, with the National Alliance of Healthcare Purchaser Coalitions and the Midwest Business Group on Health (MBGH), we urge policymakers to oppose SB2385 which would further raise health care costs for Illinois families and increasingly perpetuate healthcare consolidation by exacerbating the impact of 340B on employers and employees.